Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol.


Journal

JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033

Informations de publication

Date de publication:
01 05 2019
Historique:
pubmed: 11 4 2019
medline: 17 6 2020
entrez: 11 4 2019
Statut: ppublish

Résumé

These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines.

Identifiants

pubmed: 30969319
pii: 2730291
doi: 10.1001/jamacardio.2019.0771
doi:

Substances chimiques

Anticholesteremic Agents 0
Cholesterol, LDL 0
Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Ezetimibe EOR26LQQ24

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

473-477

Auteurs

Sarah Chuzi (S)

Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Anna Pfenniger (A)

Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Donald M Lloyd-Jones (DM)

Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Roger S Blumenthal (RS)

Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University, Baltimore, Maryland.

Sidney C Smith (SC)

Division of Cardiology, Department of Medicine, University of North Carolina, Chapel Hill.

Salim S Virani (SS)

Section of Cardiovascular Research, Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas.

Scott M Grundy (SM)

Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas.

Neil J Stone (NJ)

Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH